Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

NCT05340465 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Prematurity
Iron-deficiency
Iron Deficiency Anemia
Iron Malabsorption

Interventions

DRUG: Darbepoetin Alfa
DRUG: Low Molecular Weight Iron Dextran
DRUG: Ferumoxytol injection
DRUG: Oral iron supplements

Sponsor

University of Washington

Collaborators

[object Object]